Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134: S140-S143
DOI: 10.1055/s-0029-1222591
DOI: 10.1055/s-0029-1222591
Kurzübersicht | Review article
Schlafmedizin, Schmerztherapie
© Georg Thieme Verlag KG Stuttgart · New York
Praxisorientierte Therapie von Schmerz und Schlafdefizit
Treatment of pain and sleep deficit in general practiceFurther Information
Publication History
eingereicht: 11.11.2008
akzeptiert: 12.03.2009
Publication Date:
24 June 2009 (online)
Schlüsselwörter
Schlafmangel - Schlafdefizit - Schlaf - Schmerzpatient
Keywords
sleep deficit - sleep - pain treatment
Literatur
- 1 Eriksen J, Sjögren P, Bruera E. et al . Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain. 2006; 125 172-179
- 2 Freye E. Opioide in der Medizin. 6. Auflage,. 6. Auflage, Springer Verlag 2004 Kapitel 9.3: 67-70
- 3 Freye E, Levy J V. Einsatz der Opioide bei alten Patienten: Pharmakokinetische und pharmakodynamische Überlegungen. Anästhesiol Intensivmed Notfallmed Schmerzther. 2004; 39 527-537
- 4 Hale M, Tudor I C, Khanna S, Thipphawong J. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis. Clin Ther. 2007; 29 874-888
- 5 Kosinski M, Kavanagh S. Sleep outcomes for patients with osteoarthritis of the hip or knee: Evidence from a randomized controlled trial of once-daily OROS hydromorphone versus extended-release oxycodone. J Pain. 2006; 7, Suppl S55
- 6 Maier C. Auch Sucht ist eine Krankheit. Editorial. Der Schmerz. 2008; 22 639-643
- 7 Melzack R, Wall P D. Pain mechanism – a new theory. Science. 1965; 150 971-979
- 8 Miaskowski C. Pharmacologic management of sleep disturbances in noncancer-related pain. Pain Management Nursing. 2009; Vol. 10, Issue 1 3-13
- 9 Sabatowski R, Giesecke T. Pharmacotherapy of chronic, non tumour-related pain. Efficacy, tolerability and patient benefit of an oral osmotic system with hydromorphone. MMW Fortschr Med. 2007; 149 (Suppl 3) 119-124
- 10 Turk D C, Dworkin R H, Revicki D. et al . Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain. 2008; 137 276-285
- 11 Walker J M, Farney J R, Rhondeau S M. et al . Chronic opioid use is a risk factor in the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007; 3 455-461
- 12 Wallace M. et al . Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127). Curr Med Res Opin. 2007; 23 981-989
Dr. Wolfgang Schwarz
Schlöpke Weg 8
21357 Bardowick
Phone: 04131/925150
Fax: 04131/9251525
Email: st.marianus@t.online.de